Propagation of Protein Aggregation in Neurodegenerative Diseases
- PMID: 30917002
- DOI: 10.1146/annurev-biochem-061516-045049
Propagation of Protein Aggregation in Neurodegenerative Diseases
Abstract
Most common neurodegenerative diseases feature deposition of protein amyloids and degeneration of brain networks. Amyloids are ordered protein assemblies that can act as templates for their own replication through monomer addition. Evidence suggests that this characteristic may underlie the progression of pathology in neurodegenerative diseases. Many different amyloid proteins, including Aβ, tau, and α-synuclein, exhibit properties similar to those of infectious prion protein in experimental systems: discrete and self-replicating amyloid structures, transcellular propagation of aggregation, and transmissible neuropathology. This review discusses the contribution of prion phenomena and transcellular propagation to the progression of pathology in common neurodegenerative diseases such as Alzheimer's and Parkinson's. It reviews fundamental events such as cell entry, amplification, and transcellular movement. It also discusses amyloid strains, which produce distinct patterns of neuropathology and spread through the nervous system. These concepts may impact the development of new diagnostic and therapeutic strategies.
Keywords: aggregation; amyloid; prion; propagation; strain; tau.
Similar articles
-
Role of Different Alpha-Synuclein Strains in Synucleinopathies, Similarities with other Neurodegenerative Diseases.J Parkinsons Dis. 2015;5(2):217-27. doi: 10.3233/JPD-150543. J Parkinsons Dis. 2015. PMID: 25757830 Free PMC article. Review.
-
The prion model for progression and diversity of neurodegenerative diseases.Lancet Neurol. 2017 Apr;16(4):323-332. doi: 10.1016/S1474-4422(17)30037-6. Epub 2017 Feb 24. Lancet Neurol. 2017. PMID: 28238712 Review.
-
Prion-like propagation of α-synuclein in neurodegenerative diseases.Prog Mol Biol Transl Sci. 2019;168:323-348. doi: 10.1016/bs.pmbts.2019.07.005. Epub 2019 Jul 31. Prog Mol Biol Transl Sci. 2019. PMID: 31699325 Review.
-
What is strain in neurodegenerative diseases?Cell Mol Life Sci. 2020 Feb;77(4):665-676. doi: 10.1007/s00018-019-03298-9. Epub 2019 Sep 17. Cell Mol Life Sci. 2020. PMID: 31531680 Free PMC article. Review.
-
Mixed pathologies in pancreatic β cells from subjects with neurodegenerative diseases and their interaction with prion protein.Acta Neuropathol Commun. 2021 Apr 8;9(1):64. doi: 10.1186/s40478-021-01171-0. Acta Neuropathol Commun. 2021. PMID: 33832546 Free PMC article.
Cited by
-
Amyloid peptides with antimicrobial and/or microbial agglutination activity.Appl Microbiol Biotechnol. 2022 Dec;106(23):7711-7720. doi: 10.1007/s00253-022-12246-w. Epub 2022 Nov 2. Appl Microbiol Biotechnol. 2022. PMID: 36322251 Free PMC article. Review.
-
Quantifying Oligomer Populations in Real Time during Protein Aggregation Using Single-Molecule Mass Photometry.ACS Nano. 2022 Oct 25;16(10):16462-16470. doi: 10.1021/acsnano.2c05739. Epub 2022 Sep 20. ACS Nano. 2022. PMID: 36126253 Free PMC article.
-
Microglia Pyroptosis: A Candidate Target for Neurological Diseases Treatment.Front Neurosci. 2022 Jul 22;16:922331. doi: 10.3389/fnins.2022.922331. eCollection 2022. Front Neurosci. 2022. PMID: 35937897 Free PMC article. Review.
-
Sirtuins at the Crossroads between Mitochondrial Quality Control and Neurodegenerative Diseases: Structure, Regulation, Modifications, and Modulators.Aging Dis. 2023 Jun 1;14(3):794-824. doi: 10.14336/AD.2022.1123. Aging Dis. 2023. PMID: 37191431 Free PMC article. Review.
-
Design and Synthesis of 6-O-Phosphorylated Heparan Sulfate Oligosaccharides to Inhibit Amyloid β Aggregation.Chembiochem. 2022 Aug 3;23(15):e202200191. doi: 10.1002/cbic.202200191. Epub 2022 Jun 16. Chembiochem. 2022. PMID: 35585797 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical